Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: records (570), accounts (204), paperwork (33)

Tracheostomy - patient information

Description: This factsheet explains what a tracheostomy is, what the procedure involves and what the possible risks are.
Url: /Media/UHS-website-2019/Patientinformation/Ear-nose-and-throat/Tracheostomy-2851-PIL.pdf

Mycophenolate for interstitial lung disease (ILD) - patient information

Description: This factsheet contains useful information about the medicine mycophenolate mofetil (MMF).
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Mycophenolate-for-interstitial-lung-disease-ILD-patient-information.pdf

adamshaw.fullcalendar.license

Description: Copyright (c) 2013 Adam Shaw Permission is hereby granted, free of charge, to any person obtaining a copy of this software and assoc
Url: /SiteElements/Calendar/adamshaw.fullcalendar.license.txt

Erdafitinib

Description: Regimen • Urothelial - Erdafitinib Chemotherapy Protocol UROTHELIAL CANCER ERDAFITINIB Indication • Monotherapy treatment of unresectable or metastatic uroth
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Erdafitinib.pdf

Guide to the Mental Capacity Act - patient information

Description: This leaflet provides an overview of the Mental Capacity Act 2005.
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Guide-to-the-Mental-Capacity-Act-2865-PIL.pdf

Avelumab(800mg)

Description: Chemotherapy Protocol BLADDER CANCER AVELUMAB (800mg) Regimen  Bladder Cancer - Avelumab Indication  Avelumab is indicated as monotherapy for the first-line maintenance
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Avelumab800mg.pdf

Pembrolizumab Ver 1 skin

Description: Chemotherapy Protocol SKIN CANCER Pembrolizumab Pembrolizumab is currently available on a compassionate use basis only – not yet licensed in the UK
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinPembrolizumabVer1.pdf

Registering New Studies into the CRF

Description: SCBR University Hospitals Southampton NHS Foundation Trust Standard Operating Procedure for Accepting Registering New Projects Studies into the Southampton NIHR Wellcome
Url: /Media/Southampton-Clinical-Research/CRF-templates/Registering-New-Studies-into-the-CRF.docx

Enfortumab-Vedotin-Pembrolizumab

Description: Chemotherapy Protocol UROTHELIAL CANCER Enfortumab vedotin-Pembrolizumab (EV-P) Regimen • Urothelial – Enfortumab vedotin - Pembrolizumab Indication • First-li
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Enfortumab-Vedotin-Pembrolizumab.pdf

Papers Trust Board - 13 January 2026

Description: Date Time Location Chair Apologies Agenda Trust Board – Open Session 13/01/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-13-January-2026.pdf

61 to 70 of 83

Previous … 5 6 7 8 9 Next